Knowledge (XXG)

Dunnigan familial partial lipodystrophy

Source đź“ť

29: 1330: 384: 1396: 1022: 1296: 1258: 658: 855: 1367: 791: 741: 435: 1391: 860: 1279: 1247: 982: 258: 972: 1386: 256:
Ludtke, A; Genschel, J; Brabant, G; Bauditz, J; et al. (October 2005). "Hepatic steatosis in Dunnigan-type familial partial lipodystrophy".
1263: 1360: 1055: 932: 880: 396: 428: 1088: 173: 1083: 1002: 1353: 892: 213: 1310: 1191: 1145: 977: 967: 141: 992: 631: 1140: 1109: 1060: 937: 907: 811: 761: 731: 421: 527: 781: 715: 601: 578: 555: 517: 479: 132:
A and C. The condition is named after Scottish doctor Matthew Dunnigan, who pioneered early study into the disorder.
1180: 1161: 1078: 171:
Hegele, RA (December 2000). "Familial partial lipodystrophy: A monogenic form of the insulin resistance syndrome".
1242: 1237: 1135: 959: 710: 1017: 537: 1274: 1216: 821: 303:"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state" 146: 927: 885: 484: 674: 532: 489: 1186: 50: 648: 90: 1155: 831: 801: 771: 751: 720: 283: 238: 78: 54: 896: 583: 560: 512: 494: 332: 275: 230: 190: 114: 1337: 1123: 322: 314: 267: 222: 182: 86: 58: 1007: 689: 653: 626: 110: 98: 82: 28: 1204: 701: 522: 327: 302: 129: 70: 62: 1380: 923: 453: 271: 287: 242: 444: 106: 102: 211:
Hegele, RA (September 2000). "Insulin resistance in human partial lipodystrophy".
1270: 1233: 1199: 1038: 953: 849: 697: 643: 570: 462: 1286: 903: 827: 817: 807: 797: 787: 777: 727: 226: 1329: 1211: 1104: 767: 757: 747: 737: 705: 693: 621: 118: 74: 279: 234: 194: 186: 336: 1131: 547: 318: 94: 1336:
This article about an endocrine, nutritional, or metabolic disease is a
376: 1254: 1171: 1151: 1047: 638: 413: 1070: 876: 504: 388: 845: 841: 837: 593: 471: 66: 36:
Autosomal dominant is the manner of inheritance of this condition
1291: 401: 125: 122: 417: 1023:
Hydrops-ectopic calcification-moth-eaten skeletal dysplasia
1297:
Microcephalic osteodysplastic primordial dwarfism type II
1341: 1259:
Epidermolysis bullosa simplex with muscular dystrophy
366: 1226: 1170: 1122: 1097: 1069: 1046: 1037: 946: 916: 869: 682: 673: 614: 592: 569: 546: 503: 470: 461: 452: 370: 21: 1397:Endocrine, nutritional and metabolic disease stubs 659:Terminal osseous dysplasia with pigmentary defects 45:, also known as FPLD Type II and abbreviated as ( 792:Meesmann juvenile epithelial corneal dystrophy 742:Meesmann juvenile epithelial corneal dystrophy 206: 204: 166: 164: 162: 1361: 429: 22:Familial Partial Lipodystrophy, Dunnigan Type 8: 1280:Arrhythmogenic right ventricular dysplasia 9 1248:Arrhythmogenic right ventricular dysplasia 8 43:Dunnigan-type familial partial lipodystrophy 861:Reticular pigmented anomaly of the flexures 1368: 1354: 1043: 679: 467: 458: 436: 422: 414: 367: 27: 18: 326: 856:Naegeli–Franceschetti–Jadassohn syndrome 259:The American Journal of Gastroenterology 158: 1264:Epidermolysis bullosa simplex of Ogna 533:DFN A3, 4, 11, 17, 22; B2, 30, 37, 48 7: 1326: 1324: 881:Desmin-related myofibrillar myopathy 518:Hypertrophic cardiomyopathy 1, 8, 10 973:Emery–Dreifuss muscular dystrophy 2 301:Köbberling, J; Dunnigan, M (1986). 1392:Conditions of the subcutaneous fat 1340:. You can help Knowledge (XXG) by 1238:Striate palmoplantar keratoderma 2 933:Charcot–Marie–Tooth disease 1F, 2E 711:Striate palmoplantar keratoderma 3 14: 1089:Asphyxiating thoracic dysplasia 3 978:Limb-girdle muscular dystrophy 1B 174:Molecular Genetics and Metabolism 128:, which is the gene that encodes 1328: 1084:Short rib-polydactyly syndrome 3 1061:Hereditary spastic paraplegia 10 556:Hypertrophic cardiomyopathy 7, 2 272:10.1111/j.1572-0241.2005.00234.x 983:Charcot–Marie–Tooth disease 2B1 214:Current Atherosclerosis Reports 1387:Genetic diseases and disorders 1192:Familial adenomatous polyposis 1146:Hereditary elliptocytosis 2, 3 1056:Charcot–Marie–Tooth disease 2A 968:Familial partial lipodystrophy 480:Hypertrophic cardiomyopathy 11 142:Familial partial lipodystrophy 73:. FPLD recapitulates the main 1: 1141:Hereditary spherocytosis 2, 3 1110:Cavernous venous malformation 938:Amyotrophic lateral sclerosis 908:Amyotrophic lateral sclerosis 812:Epidermolysis bullosa simplex 762:Epidermolysis bullosa simplex 732:Ichthyosis bullosa of Siemens 602:Hypertrophic cardiomyopathy 9 579:Hypertrophic cardiomyopathy 3 782:Epidermolytic hyperkeratosis 716:Epidermolytic hyperkeratosis 1003:Buschke–Ollendorff syndrome 307:Journal of Medical Genetics 79:insulin resistance syndrome 1413: 1323: 1162:Hereditary spherocytosis 1 1079:Primary ciliary dyskinesia 485:Dilated cardiomyopathy 1AA 1306: 993:Barraquer–Simons syndrome 886:Dilated cardiomyopathy 1I 632:Weill–Marchesani syndrome 227:10.1007/s11883-000-0078-0 109:, and early endpoints of 57:characterized by loss of 35: 26: 1136:Spinocerebellar ataxia 5 960:Mandibuloacral dysplasia 528:Freeman–Sheldon syndrome 113:. It can also result in 1275:Skin fragility syndrome 1217:Giant axonal neuropathy 822:Steatocystoma multiplex 147:Priscilla Lopes-Schliep 561:Nemaline myopathy 4, 5 187:10.1006/mgme.2000.3092 1311:Cytoskeletal proteins 319:10.1136/jmg.23.2.120 117:. FPLD results from 1018:Pelger–Huet anomaly 928:Parkinson's disease 649:Boomerang dysplasia 584:Nemaline myopathy 1 538:May–Hegglin anomaly 495:Nemaline myopathy 3 91:glucose intolerance 1187:Gardner's syndrome 1156:Long QT syndrome 4 832:Familial cirrhosis 802:White sponge nevus 772:Familial cirrhosis 752:White sponge nevus 77:attributes of the 55:insulin resistance 1349: 1348: 1318: 1317: 1243:Carvajal syndrome 1118: 1117: 1033: 1032: 897:Alexander disease 669: 668: 610: 609: 523:Usher syndrome 1B 513:Elejalde syndrome 411: 410: 115:hepatic steatosis 40: 39: 16:Medical condition 1404: 1370: 1363: 1356: 1332: 1325: 1309:Related topics: 1044: 680: 468: 459: 438: 431: 424: 415: 368: 341: 340: 330: 298: 292: 291: 253: 247: 246: 208: 199: 198: 168: 87:hyperinsulinemia 59:subcutaneous fat 31: 19: 1412: 1411: 1407: 1406: 1405: 1403: 1402: 1401: 1377: 1376: 1375: 1374: 1321: 1319: 1314: 1302: 1222: 1166: 1114: 1093: 1065: 1029: 1008:Osteopoikilosis 942: 912: 865: 665: 654:Larsen syndrome 627:Marfan syndrome 606: 588: 565: 542: 499: 448: 442: 412: 407: 406: 379: 365: 359: 356: 353: 350: 347: 345: 344: 300: 299: 295: 266:(10): 2218–24. 255: 254: 250: 210: 209: 202: 170: 169: 160: 155: 138: 111:atherosclerosis 83:central obesity 17: 12: 11: 5: 1410: 1408: 1400: 1399: 1394: 1389: 1379: 1378: 1373: 1372: 1365: 1358: 1350: 1347: 1346: 1333: 1316: 1315: 1307: 1304: 1303: 1301: 1300: 1283: 1282: 1277: 1267: 1266: 1261: 1251: 1250: 1245: 1240: 1230: 1228: 1224: 1223: 1221: 1220: 1208: 1205:Naxos syndrome 1196: 1195: 1194: 1189: 1176: 1174: 1168: 1167: 1165: 1164: 1149: 1148: 1143: 1138: 1128: 1126: 1120: 1119: 1116: 1115: 1113: 1112: 1107: 1101: 1099: 1095: 1094: 1092: 1091: 1086: 1081: 1075: 1073: 1067: 1066: 1064: 1063: 1058: 1052: 1050: 1041: 1035: 1034: 1031: 1030: 1028: 1027: 1026: 1025: 1020: 1012: 1011: 1010: 1005: 997: 996: 995: 987: 986: 985: 980: 975: 970: 962: 950: 948: 944: 943: 941: 940: 935: 930: 920: 918: 914: 913: 911: 910: 900: 899: 889: 888: 883: 873: 871: 867: 866: 864: 863: 858: 853: 835: 825: 815: 805: 795: 785: 775: 765: 755: 745: 735: 725: 724: 723: 718: 713: 702:hyperkeratosis 686: 684: 677: 671: 670: 667: 666: 664: 663: 662: 661: 656: 651: 646: 636: 635: 634: 629: 618: 616: 612: 611: 608: 607: 605: 604: 598: 596: 590: 589: 587: 586: 581: 575: 573: 567: 566: 564: 563: 558: 552: 550: 544: 543: 541: 540: 535: 530: 525: 520: 515: 509: 507: 501: 500: 498: 497: 492: 487: 482: 476: 474: 465: 456: 454:Microfilaments 450: 449: 443: 441: 440: 433: 426: 418: 409: 408: 405: 404: 393: 380: 375: 374: 372: 371:Classification 364: 363:External links 361: 343: 342: 313:(2): 120–127. 293: 248: 221:(5): 397–404. 200: 157: 156: 154: 151: 150: 149: 144: 137: 134: 130:nuclear lamins 71:gluteal region 38: 37: 33: 32: 24: 23: 15: 13: 10: 9: 6: 4: 3: 2: 1409: 1398: 1395: 1393: 1390: 1388: 1385: 1384: 1382: 1371: 1366: 1364: 1359: 1357: 1352: 1351: 1345: 1343: 1339: 1334: 1331: 1327: 1322: 1313: 1312: 1305: 1298: 1294: 1293: 1288: 1285: 1284: 1281: 1278: 1276: 1272: 1269: 1268: 1265: 1262: 1260: 1256: 1253: 1252: 1249: 1246: 1244: 1241: 1239: 1235: 1232: 1231: 1229: 1225: 1218: 1214: 1213: 1209: 1206: 1202: 1201: 1197: 1193: 1190: 1188: 1185: 1184: 1183: 1182: 1178: 1177: 1175: 1173: 1169: 1163: 1160: 1159: 1158: 1157: 1153: 1147: 1144: 1142: 1139: 1137: 1133: 1130: 1129: 1127: 1125: 1121: 1111: 1108: 1106: 1103: 1102: 1100: 1096: 1090: 1087: 1085: 1082: 1080: 1077: 1076: 1074: 1072: 1068: 1062: 1059: 1057: 1054: 1053: 1051: 1049: 1045: 1042: 1040: 1036: 1024: 1021: 1019: 1016: 1015: 1013: 1009: 1006: 1004: 1001: 1000: 998: 994: 991: 990: 988: 984: 981: 979: 976: 974: 971: 969: 966: 963: 961: 958: 957: 955: 952: 951: 949: 945: 939: 936: 934: 931: 929: 925: 924:Neurofilament 922: 921: 919: 915: 909: 905: 902: 901: 898: 894: 891: 890: 887: 884: 882: 878: 875: 874: 872: 868: 862: 859: 857: 854: 851: 847: 843: 839: 836: 833: 829: 826: 823: 819: 816: 813: 809: 806: 803: 799: 796: 793: 789: 786: 783: 779: 776: 773: 769: 766: 763: 759: 756: 753: 749: 746: 743: 739: 736: 733: 729: 726: 722: 719: 717: 714: 712: 709: 708: 707: 703: 699: 695: 691: 690:Keratinopathy 688: 687: 685: 681: 678: 676: 672: 660: 657: 655: 652: 650: 647: 645: 644:FG syndrome 2 642: 641: 640: 637: 633: 630: 628: 625: 624: 623: 620: 619: 617: 613: 603: 600: 599: 597: 595: 591: 585: 582: 580: 577: 576: 574: 572: 568: 562: 559: 557: 554: 553: 551: 549: 545: 539: 536: 534: 531: 529: 526: 524: 521: 519: 516: 514: 511: 510: 508: 506: 502: 496: 493: 491: 488: 486: 483: 481: 478: 477: 475: 473: 469: 466: 464: 460: 457: 455: 451: 446: 439: 434: 432: 427: 425: 420: 419: 416: 403: 399: 398: 394: 391: 390: 386: 382: 381: 378: 373: 369: 362: 360: 357: 354: 351: 348: 338: 334: 329: 324: 320: 316: 312: 308: 304: 297: 294: 289: 285: 281: 277: 273: 269: 265: 261: 260: 252: 249: 244: 240: 236: 232: 228: 224: 220: 216: 215: 207: 205: 201: 196: 192: 188: 184: 181:(4): 539–44. 180: 176: 175: 167: 165: 163: 159: 152: 148: 145: 143: 140: 139: 135: 133: 131: 127: 124: 120: 116: 112: 108: 104: 100: 96: 92: 88: 84: 80: 76: 72: 68: 64: 60: 56: 52: 49:), is a rare 48: 44: 34: 30: 25: 20: 1342:expanding it 1335: 1320: 1308: 1290: 1210: 1198: 1179: 1150: 1039:Microtubules 964: 445:Cytoskeletal 395: 383: 358: 355: 352: 349: 346: 310: 306: 296: 263: 257: 251: 218: 212: 178: 172: 107:hypertension 103:dyslipidemia 81:, including 46: 42: 41: 1271:plakophilin 1234:desmoplakin 1200:plakoglobin 954:Laminopathy 850:Monilethrix 698:keratoderma 571:Tropomyosin 463:Myofilament 63:extremities 1381:Categories 1287:centrosome 904:Peripherin 153:References 1105:Tauopathy 694:keratosis 622:Fibrillin 119:mutations 75:metabolic 61:from the 51:monogenic 1132:Spectrin 1124:Membrane 965:Dunnigan 548:Troponin 288:23356132 280:16181372 243:38167209 235:11122771 195:11136544 136:See also 97:usually 95:diabetes 53:form of 1255:plectin 1172:Catenin 1152:Ankyrin 1048:Kinesin 956:: LMNA 639:Filamin 447:defects 392:: E88.1 337:3712389 328:1049565 1071:Dynein 999:LEMD3 877:Desmin 505:Myosin 490:DFNA20 402:151660 335:  325:  286:  278:  241:  233:  193:  99:type 2 69:, and 1227:Other 1098:Other 989:LMNB 846:KRT86 842:KRT83 838:KRT81 828:KRT18 818:KRT17 808:KRT14 798:KRT13 788:KRT12 778:KRT10 728:KRT2E 615:Other 594:Titin 472:Actin 284:S2CID 239:S2CID 67:trunk 47:FPLD2 1338:stub 1292:PCNT 1014:LBR 893:GFAP 768:KRT8 758:KRT5 748:KRT4 738:KRT3 721:IHCM 706:KRT1 397:OMIM 333:PMID 276:PMID 231:PMID 191:PMID 126:gene 123:LMNA 93:and 1212:GAN 1181:APC 704:): 683:1/2 385:ICD 323:PMC 315:doi 268:doi 264:100 223:doi 183:doi 121:in 1383:: 1289:: 1273:: 1257:: 1236:: 1154:: 1134:: 926:: 906:: 895:: 879:: 700:, 696:, 675:IF 400:: 389:10 331:. 321:. 311:23 309:. 305:. 282:. 274:. 262:. 237:. 229:. 217:. 203:^ 189:. 179:71 177:. 161:^ 105:, 101:, 89:, 85:, 65:, 1369:e 1362:t 1355:v 1344:. 1299:) 1295:( 1219:) 1215:( 1207:) 1203:( 947:5 917:4 870:3 852:) 848:( 844:/ 840:/ 834:) 830:( 824:) 820:( 814:) 810:( 804:) 800:( 794:) 790:( 784:) 780:( 774:) 770:( 764:) 760:( 754:) 750:( 744:) 740:( 734:) 730:( 692:( 437:e 430:t 423:v 387:- 377:D 339:. 317:: 290:. 270:: 245:. 225:: 219:2 197:. 185::

Index


monogenic
insulin resistance
subcutaneous fat
extremities
trunk
gluteal region
metabolic
insulin resistance syndrome
central obesity
hyperinsulinemia
glucose intolerance
diabetes
type 2
dyslipidemia
hypertension
atherosclerosis
hepatic steatosis
mutations
LMNA
gene
nuclear lamins
Familial partial lipodystrophy
Priscilla Lopes-Schliep



Molecular Genetics and Metabolism
doi
10.1006/mgme.2000.3092

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑